RT Journal Article
SR Electronic
T1 Recognizing Misleading Pharmaceutical Marketing Online
JF Journal of the American Academy of Psychiatry and the Law Online
JO J Am Acad Psychiatry Law
FD American Academy of Psychiatry and the Law
SP 219
OP 225
VO 42
IS 2
A1 Julian De Freitas
A1 Brian A. Falls
A1 Omar S. Haque
A1 Harold J. Bursztajn
YR 2014
UL http://jaapl.org/content/42/2/219.abstract
AB In light of decision-making psychology, this article details how drug marketing operates across established and novel web domains and identifies some common misleading trends and influences on prescribing and patient-initiated medication requests. The Internet has allowed pharmaceutical marketing to become more salient than ever before. Although the Internet's growth has improved the dissemination of pharmaceutical information, it has also led to the increased influence of misleading pharmaceutical marketing. Such mismarketing is of concern, especially in psychiatry, since psychotropics generate considerable revenue for drug companies. In a climate of resource-limited drug regulation and time-strapped physicians, we recommend improving both independent monitoring and consumer awareness of Internet-enabled, potentially misleading, pharmaceutical marketing influences.